No abstract available
Publication types
-
Comparative Study
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage*
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
Bevacizumab
-
Diabetes Mellitus, Type 2 / complications
-
Diabetic Retinopathy / drug therapy
-
Diabetic Retinopathy / physiopathology
-
Diabetic Retinopathy / surgery
-
Diabetic Retinopathy / therapy*
-
Female
-
Fluorescein Angiography
-
Humans
-
Intravitreal Injections
-
Laser Coagulation*
-
Male
-
Middle Aged
-
Prospective Studies
-
Retinal Neovascularization / drug therapy
-
Retinal Neovascularization / physiopathology
-
Retinal Neovascularization / surgery
-
Retinal Neovascularization / therapy*
-
Retreatment
-
Tomography, Optical Coherence
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Visual Acuity / physiology
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Bevacizumab